1Weghofer M, Thomasw WR, Pittner G, et al. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two dimensional immunoblotting and quantitative immunoglobulin E inhibitions[J]. Clin Exp Allergy, 2005,35(10) : 1384-1391.
2Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen specific immunotherapy [J]. Allergy, 2006, 61(82 Suppl) :1-20.
6Passalacqua G, Guerra L, Pasquali M. et al. Efficacy and safety of sublingual immunotherapy [J]. Annals of Allergy, Asthma &Immunology, 2004,93(6) :3-12.
7Dunsky E, Goldslein M, Dvorin D, et al. Anaphylaxis to sublingual immunotherapy[J]. Allergy, 2006,61 (10) : 1235.
8Lombardi C, Gargioni S, Cottini M, et al. The safety of sublingual immunotherapy with one or more allergens in adults [J]. Allergy,2008,63(3):375-376.
9Eifan AO, Keles S, Bahceeiler NN, et al. Anaphylaxis to multiple pollen allergen sublingual immunotherapy [J]. Allergy, 2007, 62(5) :567-568.
10Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age[J]. Chest,2008,133(3) :599-609.
4Maling HJ, Abreu-Nogueim J, Alvarcz-Cuesta E, et al. Local immunotherapy [ J ]. Alergy, 1998,53 (10) : 933 - 944.
5Frew A J, Smith HE. Sublingual immunotherapy [J]. J Allergy Clin Immunol,2001, 107 : ( 3 ) :441 - 444.
6Bagnasco M,Passalacqua G, Villa G,et al. Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers [ J ]. Clin Exp Allergy. 2001,31 ( 1 ) :54 -60.
7Ohashi Y,Nakai Y, Tanaka A, et al. Allergen-specific immunotherapy for allergic rhinitis: a new insight into its clinical efficacy and mechanism [J].Acta Otolaryngol Suppl, 1998,538 : 178 - 190.
8Bahceciler NN,Arikan C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites[J].Int Arch Allergy Immunol, 2005,136 ( 3 ) : 287 - 294.
